RDF/XMLNTriplesTurtleShow queryShare
SubjectPredicateObject
http://purl.uniprot.org/citations/37130519http://www.w3.org/1999/02/22-rdf-syntax-ns#typehttp://purl.uniprot.org/core/Journal_Citation
http://purl.uniprot.org/citations/37130519http://www.w3.org/2000/01/rdf-schema#comment"The natural product family of the fusicoccanes (FCs) has been shown to display anti-cancer activity, especially when combined with established therapeutic agents. FCs stabilize 14-3-3 protein-protein interactions (PPIs). Here, we tested combinations of a small library of FCs with interferon α (IFNα) on different cancer cell lines and report a proteomics approach to identify the specific 14-3-3 PPIs that are induced by IFNα and stabilized by FCs in OVCAR-3 cells. Among the identified 14-3-3 target proteins are THEMIS2, receptor interacting protein kinase 2 (RIPK2), EIF2AK2, and several members of the LDB1 complex. Biophysical and structural biology studies confirm these 14-3-3 PPIs as physical targets of FC stabilization, and transcriptome as well as pathway analyses suggest possible explanations for the observed synergistic effect of IFNα/FC treatment on cancer cells. This study elucidates the polypharmacological effects of FCs in cancer cells and identifies potential targets from the vast interactome of 14-3-3s for therapeutic intervention in oncology."xsd:string
http://purl.uniprot.org/citations/37130519http://purl.org/dc/terms/identifier"doi:10.1016/j.chembiol.2023.04.005"xsd:string
http://purl.uniprot.org/citations/37130519http://purl.uniprot.org/core/author"Brunsveld L."xsd:string
http://purl.uniprot.org/citations/37130519http://purl.uniprot.org/core/author"Kaiser M."xsd:string
http://purl.uniprot.org/citations/37130519http://purl.uniprot.org/core/author"Higuchi Y."xsd:string
http://purl.uniprot.org/citations/37130519http://purl.uniprot.org/core/author"Kato N."xsd:string
http://purl.uniprot.org/citations/37130519http://purl.uniprot.org/core/author"Ottmann C."xsd:string
http://purl.uniprot.org/citations/37130519http://purl.uniprot.org/core/author"Kaschani F."xsd:string
http://purl.uniprot.org/citations/37130519http://purl.uniprot.org/core/author"Eickhoff J."xsd:string
http://purl.uniprot.org/citations/37130519http://purl.uniprot.org/core/author"Wolf A."xsd:string
http://purl.uniprot.org/citations/37130519http://purl.uniprot.org/core/author"Choidas A."xsd:string
http://purl.uniprot.org/citations/37130519http://purl.uniprot.org/core/author"Arkin M."xsd:string
http://purl.uniprot.org/citations/37130519http://purl.uniprot.org/core/author"Menninger S."xsd:string
http://purl.uniprot.org/citations/37130519http://purl.uniprot.org/core/author"Klebl B."xsd:string
http://purl.uniprot.org/citations/37130519http://purl.uniprot.org/core/author"Andrei S.A."xsd:string
http://purl.uniprot.org/citations/37130519http://purl.uniprot.org/core/author"Centorrino F."xsd:string
http://purl.uniprot.org/citations/37130519http://purl.uniprot.org/core/author"Heilmann G."xsd:string
http://purl.uniprot.org/citations/37130519http://purl.uniprot.org/core/author"Ninck S."xsd:string
http://purl.uniprot.org/citations/37130519http://purl.uniprot.org/core/author"Andlovic B."xsd:string
http://purl.uniprot.org/citations/37130519http://purl.uniprot.org/core/date"2023"xsd:gYear
http://purl.uniprot.org/citations/37130519http://purl.uniprot.org/core/name"Cell Chem Biol"xsd:string
http://purl.uniprot.org/citations/37130519http://purl.uniprot.org/core/pages"573-590.e6"xsd:string
http://purl.uniprot.org/citations/37130519http://purl.uniprot.org/core/title"IFNalpha primes cancer cells for Fusicoccin-induced cell death via 14-3-3 PPI stabilization."xsd:string
http://purl.uniprot.org/citations/37130519http://purl.uniprot.org/core/volume"30"xsd:string